Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 372 of 1,261
  1. US 10889556

    Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease

    The Regents of the University of California · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  2. US 10888597

    Composition for treating brain stroke

    ENLIVEN BIOTECHNOLOGY CO, LTD. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  3. US 10888589

    Modulation of stem cells using zinc finger proteins

    Sangamo Therapeutics, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  4. US 10888601

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  5. US 10889561

    Process of making somatostatin modulators

    CRINETICS PHARMACEUTICALS, INC. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  6. US 10888565

    Compounds and compositions for ossification and methods related thereto

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  7. US 10888517

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  8. US 10888558

    Regimens of tafenoquine for prevention of malaria in malaria-naive subjects

    The Government of the United States, as represented by the Secretary of the Army · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  9. US 10888516

    Soluble estradiol capsule for vaginal insertion

    Compass Therapeutics LLC · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  10. US 10889625

    Peptide-based methods for treating neurological injury

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  11. US 10889834

    Methods and compositions for enhancing targeted transgene integration

    Sangamo Therapeutics, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  12. US 10889817

    Oligonucleotide therapy for Leber Congenital Amaurosis

    ProQR Therapeutics II B.V. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  13. US 10889813

    Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  14. US 10889592

    Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

    Valo Early Discovery, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  15. US 10889580

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  16. US 10889587

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  17. US 10889607

    Sialic acid analogs

    Ultragenyx Pharmaceutical Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  18. US 10888617

    Cured oil-hydrogel biomaterial compositions for controlled drug delivery

    ATRIUM MEDICAL CORPORATION · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  19. US 10888618

    Method of treating cancer

    Intensity Therapeutics, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  20. US 10888619

    Stable aqueous etanercept composition

    Coherus BioSciences, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  21. US 10889543

    Fine-tune modulators of neuronal excitability for neuropsychiatric disorders

    The Board of Regents of the University of Texas System · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  22. US 10889538

    Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same

    The Regents of the University of California · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  23. US 10888499

    Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom

    Aquestive Therapeutics, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted
  24. US 10889562

    Prodrugs of Nrf2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.